Researcher
Beppe Floris
- Disciplines:Macromolecular and materials chemistry, Laboratory medicine, Morphological sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From29 Oct 2007 → 2 Feb 2011 - Translational Cell & Tissue Research (Division)
Member
From12 May 2004 → Today
Projects
1 - 10 of 20
- Atlas of therapeutic targets in metastatic breast cancer.From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- The changing HER2 biomarker testing policy: Impact and training for the Belgian pathology laboratoriesFrom12 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- MetLob: A post-mortem tissue donation study dedicated to Metastatic Lobular breast cancerFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Histopathological heterogeneity of metastatic breast cancerFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Quality improvement of diagnostic processes in the oncology fieldFrom18 Oct 2021 → 15 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of the tumor microenvironment of breast cancer metastasesFrom11 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- UPTIDER (UZ/KU Leuven Program for post-mortem Tissue Donation to Enhance Research), a unique setting to unravel treatment resistance and disease progression in patients with breast cancer.From1 Oct 2021 → TodayFunding: BOF - projects
- FAT-IBC: Facing adiposity in personalizing treatment of Inflammatory Breast Cancer patients.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Improving immuno-oncology diagnostics by high-dimensional correlation analysis of histopathology and proteomics data in breast cancer samplesFrom4 Sep 2020 → 22 Feb 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Clinical, pathological and molecular characterization of invasive lobular carcinoma (ILC)From12 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 169
- Correlation of TROP-2 expression with clinical-pathological characteristics and outcome in triple-negative breast cancer(2022)
Authors: Hava Izci, Annouschka Laenen, Hans Wildiers, Christine Desmedt, Ann Smeets, Sileny Han, Ines Nevelsteen, Patrick Neven, Beppe Floris
- Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop(2022)
Authors: Yichao Hua, Gerlanda Vella, Ann Smeets, David Nittner, Francesca Bosisio, Beppe Floris, Diether Lambrechts, Chris Marine, Susan Schlenner, Gabriele Bergers
Pages: 1600 - + - Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer.(2022)
Authors: Maxim De Schepper, Karen Van Baelen, François Richard, Beppe Floris, Christine Desmedt
Pages: 1812 - 1820 - Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights(2022)
Authors: Sophia Leduc, Beppe Floris, Maxim De Schepper, Christine Desmedt
Pages: 988 - 1013 - Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast(2022)
Authors: Liliana Sokol, Maxim De Schepper, Edoardo Isnaldi, Anh-Co Truong, François Richard, Ann Smeets, Ines Nevelsteen, Birgit Weynand, Christine Desmedt, Patrick Neven, et al.
- Incorporating progesterone receptor expression into the PREDICT breast prognostic model(2022)
Authors: Beppe Floris, Diether Lambrechts
Pages: 178 - 193 - The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer.(2022)
Authors: Edoardo Isnaldi, François Richard, Maxim De Schepper, Sophia Leduc, Tatjana Geukens, Karen Van Baelen, Ha Linh Nguyen, Beppe Floris, Christine Desmedt
Pages: 90 - The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer(2022)
Authors: Edoardo Isnaldi, François Richard, Maxim De Schepper, Sophia Leduc, Tatjana Geukens, Karen Van Baelen, Ha Linh Nguyen, Beppe Floris, Christine Desmedt
- Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer(2022)
Authors: Karen Van Baelen, Tatjana Geukens, François Richard, Chantal Van Ongeval, Maxim De Schepper, Edoardo Isnaldi, Ines Nevelsteen, Ann Smeets, Hans Wildiers, Beppe Floris, et al.
Pages: 769 - 785 - External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices(2022)
Authors: Nele Laudus, Beppe Floris, Els Dequeker